The Centers for Disease Control and Prevention (CDC) is investigating a multistate outbreak of extensively drug-resistant Salmonella infections linked to Rosabella brand moringa powder capsules distributed by Ambrosia Brands, LLC.
Seven cases have been reported across seven states, with three hospitalizations and no deaths as of February 13. The outbreak strain is resistant to all first-line and alternative antibiotics commonly recommended for Salmonella, and carries an NDM-1 carbapenemase gene, meaning it may also be resistant to carbapenems. According to CDC, this is the first documented outbreak of Salmonella with an NDM-1 gene in the United States.
The capsules are sold in white plastic bottles with a green label, covering 52 lot codes with 2027 expiration dates. The product was available nationwide primarily through the company's website, Amazon, TikTok Shop, Shein, and eBay. The firm has agreed to a voluntary recall. Specific lot codes are available on FDA's website.
This is a separate investigation from CDC's January outbreak of Salmonella, also linked to moringa leaf powder supplements.
Recommended Actions
- Ask patients with Salmonella symptoms about dietary supplement use, including moringa products. Advise patients to discard affected Rosabella brand moringa powder capsules.
- Refer to CDC's guidance for health care providers for a clinical overview, including diagnosis, treatment and patient counseling.
- Report laboratory-confirmed infections to your state or local health department.
|